Cost implications of post-surgical morbidity following blood transfusion in cancer patients undergoing elective colorectal resection: An evaluation in the US hospital setting

Current Medical Research and Opinion

Volumn 21, Issue 3, 2005, Pages 447-455

  Guest, Julian F ^a   Ruiz, Francis J ^a   Tang, Reiping ^b   Wang, Jeng Yi ^b   Changchien, Chung R ^b   Wexner, Steven ^c   Choti, Michael A ^d  

^a CATALYST Health Economics Consultants   (United Kingdom)

^b CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^c LERNER RESEARCH INSTITUTE   (United States)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Blood transfusions; Colorectal cancer; Costs; Economics; Resource use; Surgical site infections

Indexed keywords

ARTICLE; BLOOD TRANSFUSION; CANCER PATIENT; COLON RESECTION; COLORECTAL CANCER; COLORECTAL SURGERY; CONTROLLED STUDY; DATA ANALYSIS; ELECTIVE SURGERY; HEALTH CARE COST; HOSPITAL; HUMAN; LAPAROTOMY; MAJOR CLINICAL STUDY; MODEL; MORBIDITY; POSTOPERATIVE PERIOD; RECTUM RESECTION; SURGICAL INFECTION; TAIWAN; UNITED STATES;

BLOOD TRANSFUSION; COLORECTAL NEOPLASMS; DECISION TREES; ECONOMICS, PHARMACEUTICAL; HEALTH CARE COSTS; HOSPITALS; HUMANS; MODELS, THEORETICAL; MORBIDITY; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; SURGICAL PROCEDURES, ELECTIVE; UNITED STATES;

EID: 16844361866     PISSN: 03007995     EISSN: None     Source Type: Journal    
DOI: 10.1185/030079905X30734     Document Type: Article

References (37)

1. Gwyn K, Sinicrope FA. Chemoprevention of colorectal cancer. Am J Gastroenterol 2002;97(1):13-21
2. Jemal A, Murray T, Samuels A, et al. Cancer Statistics 2003 CA. A Cancer Journal for Clinicians 2003;53:5-26
3. CCCG, Colorectal Cancer Collaborative Group. Palliative chemotherapy for advanced colorectal cancer: systematic review and meta-analysis. Br Med J 2000;321:531-5
4. Chiappa A, Zbar AP, Bertani E, et al. Surgical outcomes for colorectal cancer patients including the elderly. Hepato-Gastroenterol 2001;48(38):440-4
5. Edna TH, Bjerkeset T. Association between transfusion of stored blood and infective bacterial complications after resection for colorectal cancer. Eur J Surg 1998;164(6):449-56
6. Benoist S, Panis Y, Pannegeon V, et al. Predictive factors for perioperative blood transfusions in rectal resection for cancer: a multivariate analysis of a group of 212 patients. Surgery 2001;129(4):433-9
7. Torchia MG, Danzinger RG. Perioperative blood transfusion and albumin administration are independent risk factors for the development of postoperative infections after colorectal surgery. Can. J Surg 2000;43(3):212-6
8. Vamvakas EC, Carven JH, Hibberd PL. Blood transfusion and infection after colorectal cancer surgery. Transfusion 1996;36(11-12):1000-8
9. Tang R, Chen HH, Wang YL, et al. Risk factors for surgical site infection after elective resection of the colon and rectum; a single-center prospective study of 2809 consecutive patients. Ann Surg 2001;234(2):181-9
10. Fry DE. The economic costs of surgical site infection. Surg Infect 2002;3(Suppl 1):S37-43
11. Horan TC, Gaynes RP, Martone WJ, et al. CDC definitions of nosocomial surgical site infections, 1992: a modification of CDC definitions of surgical wound infections. Am J Infect Control 1992;20:271-4
12. Tucker J, Ambroze W, Orangio G, et al. Laparoscopically assisted bowel surgery - analysis of 114 cases. Surg Endosc 1995;9(3):297-300
13. Chen HH, Iroatulam AJ, Alabaz O, et al. Laparoscopic colectomy is superior to laparotomy for reduction of disability in patients with colorectal adenoma. Changgeng Yi Xue Za Zhi 1999;22(4):586-92
14. Centers for Medicaid and Medicare Services. 2002 national physician fee schedule relative value file (for procedural costs). Available from: URL:http://cms.hhs.gov/providers/pufdownload/carrpuf.asp [accessed June 2002]
15. Centers for Medicaid and Medicare Services. 2002 parenteral and enteral nutrition items and services (PEN) fee schedule. Available from: URL:http://cms.hhs.gov/ [accessed June 2002]
16. Centers for Medicaid and Medicare Services. 2002 clinical diagnostic laboratory fee schedule. Available from: URL:http://cms.hhs.gov/ [accessed June 2002]
17. 1999 Hospital and hospital health care complex data set (ICU and general ward unit costs). Health Care Financing Administration (HCFA). Hospital and hospital health care complex cost report, Form HCFA-2552-96. Baltimore, Maryland
18. Anon. Redbook 2002. Montvale (NJ): Medical Economics Company, Inc.; 2002
19. Catalyst Health Economics Consultants Ltd: Data on file, 2002
20. Sennett C. Defining and measuring costs. In: Grady ML, Weis KA, editors. Cost analysis methodology for clinical practice guidelines. Agency for Health Care Policy and Research. Rockville, MD: US Department of Health and Human Services; 1995 Mar. AHCPR Pub No 95-0001, 1995
21. Centers for Medicare and Medicaid Services. Health care indicators: Table 8: index levels of medical prices: 1997-2001. Available from URL:http://www.hcfa.gov/stats/indicatr/tables [accessed July 2002]
22. Vamvakas EC, Carven JH. Allogeneic blood transfusion, hospital charges, and length of hospitalization: a study of 487 consecutive patients undergoing colorectal cancer resection. Arch Pathol Lab Med 1998;122(2):145-51
23. Pfeifer J, Wexner SD, Reissman P, et al. Laparoscopic versus open colon surgery. Cost and outcome. Surg Endosc 1995;9(12):1322-6
24. Musser D, Boorse R, Madera R, Reeves B. Laparoscopic colectomy at what cost? Surg Endosc 1994;4(1):1-5
25. Vamvakas EC, Carven JH. Transfusion of white-cell containing allogeneic blood components and postoperative wound infection: effect of confounding factors. Transfus Med 1998;8(1):29-36
26. Henry DA, Moxey AJ, Carless PA, et al. Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev 2001;(1):CD001886
27. Friederich PW, Henny CP, Messelink EJ, et al. Effect of recombinant activated factor VII on perioperative blood loss in patients undergoing retropubic prostatectomy: a double-blind placebo-controlled randomised trial. Lancet 2003;361:201-5
28. Braga M. Randomized multicentre trial of the influence of recombinant human erythropoietin on intraoperative and post-operative transfusion need in anaemic patients undergoing right hemicolectomy for carcinoma. Br J Surg 1998;85(9);1306-7
29. Qvist N, Boesby S, Wolff B, et al. Recombinant human erythropoietin and hemoglobin concentration at operation during the postoperative period: reduced need for blood transfusions in patient undergoing colorectal surgery - prospective double-blind placebo-controlled study. World J Surg 1999;23(1):30-5
30. Harmon JW, Tang DG, Gordon TA, et al. Hospital volume can serve as a surrogate for surgeon volume for achieving excellent outcomes in colorectal resection. Ann Surg 1999;230(3):404-13
31. Vardulaki, KA, Bennett-Lloyd, BD, Parfitt J, et al. A systematic review of the effectiveness and cost-effectiveness of laparoscopic surgery for colorectal cancer. National Institute for Clinical Excellence: London; 2000
32. Chiarugi M, Buccianti P, Disarli M, et al. Effect of blood transfusions on disease-free interval after rectal cancer surgery. Hepato-Gastroenterol 2000;47(34):1002-5
33. Eroglu A, Sever N, Altinok M, et al. Risk factors associated with local recurrence after curative resection for rectal cancer. Surg Today 1997;27(12):1113-8
34. The Swiss Group for Clinical Cancer Research (SAKK). Association between blood transfusion and survival in a randomised multicentre trial of perioperative adjuvant portal chemotherapy in patients with colorectal cancer, 120. Eur J Surg 1997;163(9):693-701
35. Edna TH, Bjerkeset T. Perioperative blood transfusions reduce long-term survival following surgery for colorectal cancer. Dis Colon Rectum 1998;41(4):451-9
36. Staudacher C, Chiappa A, Zbar AP, et al. Curative resection for colorectal cancer in the elderly. Prognostic factors and five-year follow-up. Ann Italian Chirugie 2000;71(4):491-6
37. Amato AC, Pescatori M. Effect of perioperative blood transfusions on recurrence of colorectal cancer, meta-analysis stratified on risk factors. Dis Colon Rectum 1998;41(5):570-85